Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.99 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.322EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.416EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.239EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.375EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.432EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.241EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.298EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.433EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.39EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.561EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.605EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.29EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.596EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
W.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.565EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.361EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.101EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.478EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.86EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.543EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.139EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.31EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.221EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.362EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.265EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.585EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.351EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.213EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.341EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.89EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.30EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.315EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.204EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.50EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.170EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.232EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.84EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.76EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.301EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.269EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.234EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Z.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
V.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used